Cellectar Biosciences, Inc. · NASDAQ:CLRB
Cellectar Biosciences, Inc. shareholders
As of Jun 30, 2026, 28 institutions reported holding Cellectar Biosciences, Inc., 36.8% of its shares. Largest: Caligan Partners LP, Nantahala Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cellectar Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Caligan Partners LP | 470K | 5.0% | new | Aug 14, 2026 |
| Nantahala Capital Management, LLC | 440K | 4.7% | new | Aug 19, 2026 |
| Vanguard | 374K | 4.0% | +275K | Aug 13, 2026 |
| Stempoint Capital LP | 355K | 3.8% | held for review | Aug 14, 2026 |
| Silverarc Capital Management, LLC | 322K | 3.4% | new | Aug 13, 2026 |
| Bleichroeder LP | 289K | 3.1% | +189K | Aug 13, 2026 |
| Jupiter Topco LLC | 274K | 2.9% | first report | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 220K | 2.3% | new | Aug 14, 2026 |
| Empery Asset Management, LP | 190K | 2.0% | new | Aug 11, 2026 |
| Diadema Partners LP | 138K | 1.5% | new | Aug 14, 2026 |